Hansoh Pharmaceutical Group Company Ltd
F:3KY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hansoh Pharmaceutical Group Company Ltd
F:3KY
|
CN |
|
S
|
Svas Biosana SpA
MIL:SVS
|
IT |
|
B
|
Burckhardt Compression Holding AG
XMUN:B5H
|
CH |
|
S
|
Sayona Mining Ltd
F:DML
|
AU |
|
Medipal Holdings Corp
F:59Z
|
JP |
|
China Everbright Bank Co Ltd
F:C0V
|
CN |
|
M
|
MicroVision Inc
XMUN:MVIN
|
US |
|
C
|
Ctp NV
PSE:CTPNV
|
NL |
|
G
|
G-III Apparel Group Ltd
F:GI4
|
US |
|
P
|
Proteome Sciences PLC
F:PI2
|
UK |
|
BCE Inc
TSX:BCE
|
CA |
|
AST SpaceMobile Inc
F:3ZU0
|
US |
|
N
|
Nordson Corp
SWB:ND1
|
US |
|
D
|
DigitalOcean Holdings Inc
XBER:0SU
|
US |
|
A
|
Axos Financial Inc
SWB:BB4
|
US |
|
A
|
American Eagle Outfitters Inc
F:AFG
|
US |
|
Blue Hat Interactive Entertainment Technology
F:4Y80
|
CN |
|
B
|
Bottomline Technologies Inc
F:BOT
|
US |
|
Senko Group Holdings Co Ltd
F:7WE
|
JP |
|
C
|
CITIC Securities Co Ltd
XMUN:CI9
|
CN |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
XBER:AIL
|
FR |
Wall St Price Targets
3KY Price Targets Summary
Hansoh Pharmaceutical Group Company Ltd
According to Wall Street analysts, the average 1-year price target for 3KY is 4.534 EUR with a low forecast of 3.719 EUR and a high forecast of 5.29 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3KY's stock price target?
Price Target
4.534
EUR
According to Wall Street analysts, the average 1-year price target for 3KY is 4.534 EUR with a low forecast of 3.719 EUR and a high forecast of 5.29 EUR.
What is the Revenue forecast for Hansoh Pharmaceutical Group Company Ltd?
Projected CAGR
15%
Over the last 8 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 8 years is 15%.
What is the Operating Income forecast for Hansoh Pharmaceutical Group Company Ltd?
Projected CAGR
15%
Over the last 8 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 8 years is 15%.
What is the Net Income forecast for Hansoh Pharmaceutical Group Company Ltd?
Projected CAGR
20%
Over the last 8 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 8 years is 20%.
